chemotherapy in patients with
A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma
โ Scribed by Masato Hareyama; Koh-ichi Sakata; Hiroki Shirato; Takeshi Nishioka; Masamichi Nishio; Keishiro Suzuki; Akio Saitoh; Atsushi Oouchi; Satoshi Fukuda; Tetsuo Himi
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 84 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. The aim of this trial was to compare the outcome achieved with neoadjuvant chemotherapy followed by radiotherapy to that achieved with radiotherapy alone for patients with locoregionally advanced undifferentiated or poorly differentiated nasopharyngeal carcinoma (NPC) meeting one of
## Background: Surgery is considered the standard treatment for operable esophageal carcinoma, although there is no compelling evidence that surgery can achieve better results than radiotherapy. there has previously been no direct randomized comparison of these two modalities with survival or disea
## Abstract ## BACKGROUND. Thalidomide is an antiangiogenic agent with immune modulating potential. The objective of this study was to determine response rates among women who were treated for recurrent ovarian cancer using topotecan with or without thalidomide. ## METHODS. Women were enrolled i
A prospective randomized trial of 157 patients with malignant astrocytoma (Grade I11 or IV) was carried out at a single institution. The minimization technique ensured balanced distribution of prognostic factors between the treatment groups. All received oral lomustine (CCNU, 80 mg/m2) six weekly an